Noninvasive arrhythmia risk assessment in guiding pharmacologic therapy for prevention of sudden cardiac death: where do we stand? Where do we go?
Verrier
Richard L
RL
Josephson
Mark E
ME
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D015195:Drug Design; D006801:Humans; D018570:Risk Assessment
D000889:Anti-Arrhythmia Agents